1. Academic Validation
  2. NDUFA9 point mutations cause a variable mitochondrial complex I assembly defect

NDUFA9 point mutations cause a variable mitochondrial complex I assembly defect

  • Clin Genet. 2018 Jan;93(1):111-118. doi: 10.1111/cge.13089.
F Baertling 1 2 L Sánchez-Caballero 1 M A M van den Brand 1 C-W Fung 3 S H-S Chan 3 V C-N Wong 3 D M E Hellebrekers 4 I F M de Coo 5 J A M Smeitink 1 R J T Rodenburg 1 L G J Nijtmans 1
Affiliations

Affiliations

  • 1 Department of Pediatrics, Radboud Center for Mitochondrial Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
  • 2 Department of General Pediatrics, Neonatology and Pediatric Cardiology, University Children's Hospital Düsseldorf, Heinrich Heine University, Düsseldorf, Germany.
  • 3 Department of Paediatrics and Adolescent Medicine, Queen Mary Hospital, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, Hong Kong.
  • 4 Department of Clinical Genetics, Maastricht University Medical Centre (MUMC), Maastricht, the Netherlands.
  • 5 Department of Neurology, Erasmus MC, Rotterdam, the Netherlands.
Abstract

Mitochondrial respiratory chain complex I consists of 44 different subunits and contains 3 functional modules: the Q-, the N- and the P-module. NDUFA9 is a Q-module subunit required for complex I assembly or stability. However, its role in complex I biogenesis has not been studied in patient fibroblasts. So far, a single patient carrying an NDUFA9 variant with a severe neonatally fatal phenotype has been reported. Via exome sequencing, we identified a novel homozygous NDUFA9 missense variant in another patient with a milder phenotype including childhood-onset progressive generalized dystonia and axonal peripheral neuropathy. We performed complex I assembly analysis using primary skin fibroblasts of both patients. Reduced complex I abundance and an accumulation of Q-module subassemblies were present in both patients but more pronounced in the severe clinical phenotype patient. The latter displayed additional accumulation of P-module subassemblies, which was not present in the milder-phenotype patient. Lentiviral complementation of both patient fibroblast cell lines with wild-type NDUFA9 rescued complex I deficiency and the assembly defects. Our report further characterizes the phenotypic spectrum of NDUFA9 deficiency and demonstrates that the severity of the clinical phenotype correlates with the severity of the effects of the different NDUFA9 variants on complex I assembly.

Keywords

NDUFA9; OXPHOS; assembly; complex I; point mutation.

Figures